Practical considerations for prostate hypofractionation in the developing world
Nature Reviews Urology, Published online: 13 August 2021; doi:10.1038/s41585-021-00498-6Conventionally fractionated external beam radiotherapy is an effective treatment for localized prostate cancer, but long treatment programmes result in a substantial burden to patients and the health-care system, which is particularly problematic in low-income and middle-income countries (LMICs) where health-care resources might be scarce and patient funds limited. Here, the authors discuss the outcomes and benefits of hypofractionation — in terms of both oncology and economics — and how it could be used to improve prostate cancer care in LMICs.
Source: Nature Reviews Urology - Category: Urology & Nephrology Authors: Michael Yan Andre G. Gouveia Fabio L. Cury Nikitha Moideen Vanessa F. Bratti Horacio Patrocinio Alejandro Berlin Lucas C. Mendez Fabio Y. Moraes Source Type: research
More News: Cancer | Cancer & Oncology | Economics | External Beam Therapy | Health Management | Men | Prostate Cancer | Urology & Nephrology